In Vitro Transcription

The use of in vitro transcription is on the rise due to Introduction of CRISPR gene editing technologies that use guide RNAs to target specific genomic locations, and the generation and identification of RNA aptamers that bind specific targets.

Lucigen is now the sole provider of the highly popular AmpliScribe™ and Durascribe® T7-based in vitro transcription kits which offer quick protocols and high yields of RNA for these demanding applications.